None of France’s pharmaceutical companies have signed a contract with Russia to produce its Sputnik V COVID-19 vaccine, a spokesman for France’s industry ministry said on Tuesday. The French reaction followed media reports by the head of Russia’s RDIF sovereign wealth fund stating an agreement had been sealed. Earlier, the head of RDIF said his organization had struck deals with production facilities in Italy, Spain, France and Germany to manufacture the Russian vaccine. “We have not identified a site which meets their requirements,” the French spokesperson added.
Source: Euractiv
Teltonika has announced it is halting the construction of its EUR 3.5bn High-Tech Hill park…
Hungary’s electricity market has become a focal point for speculative trading, driven by a combination…
Central and Eastern Europe (CEE) is a rising force in artificial intelligence (AI) and startups…
The European Commission (EC) analyses the accession prospects of all ten prospective members of the…
As Donald Trump officially declared his victory in the US election, he received congratulations from…
European leaders committed to developing a defence industry base and enhancing EU competitiveness at an…